GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CRDF · Dec 31, 2024

Cardiff Oncology, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000950170-25-028992General Corporate
Capex intensity30thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

11.71% · OPTIONAL · VALID

Operating cash generation90thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-5518.74% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

39.96% · CORE · NOT_ENOUGH_HISTORY

Operating margin90thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.operating_margin

-7123.13% · CORE · VALID

SBC intensity20thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

696.93% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.00%
Current
11.71%
Delta
11.71%
Cash Generation Increased
Previous
-6336.97%
Current
-5518.74%
Delta
818.23%
Growth Increased
Previous
17.02%
Current
39.96%
Delta
22.94%
Profitability Increased
Previous
-7636.97%
Current
-7123.13%
Delta
513.84%
Sbc Intensity Decreased
Previous
759.39%
Current
696.93%
Delta
-62.47%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.